Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaremba

Showing results (891-900 of 967) with videos related to

Pageof 97
Sort By:
The Lancet. Psychiatry|March 25, 2019
Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational studyNils Opel, Ronny Redlich, Katharina Dohm, et al.
Psychological Medicine|April 24, 2019
Influence of electroconvulsive therapy on white matter structure in a diffusion tensor imaging studyJonathan Repple, Susanne Meinert, Irene Bollettini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanomaLea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Einstein (Sao Paulo, Brazil)|January 29, 2015
From one side to the other: what is essential? Perception of oncology patients and their caregivers in the beginning of oncology treatment and in palliative careBruna Antenussi Munhoz, Henrique Soares Paiva, Beatrice Martinez Zugaib Abdalla, et al.
The British Journal of Dermatology|February 20, 2026
Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanomaGeorg Lodde, Jonida Dollani, Wolfgang Galetzka, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2026
Exploring the gap between sensor-detected (SDH) and person-reported hypoglycaemia (PRH): The voice of people living with diabetesMonika Cigler, Omaima El-Hakouni, Renald Mecani, et al.
The British Journal of Dermatology|February 18, 2020
GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanomaE Livingstone, A Zaremba, S Horn, et al.
Diabetologia|July 30, 2024
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS appUffe Søholm, Melanie Broadley, Natalie Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyCarl M Thielmann, Johanna Matull, Anne Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2023
Characterisation and outcome of RAC1 mutated melanomaGeorg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Pageof 97

Showing results (891-900 of 967) with videos related to

Sort By:
Pageof 97
The Lancet. Psychiatry|March 25, 2019
Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational studyNils Opel, Ronny Redlich, Katharina Dohm, et al.
Psychological Medicine|April 24, 2019
Influence of electroconvulsive therapy on white matter structure in a diffusion tensor imaging studyJonathan Repple, Susanne Meinert, Irene Bollettini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanomaLea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Einstein (Sao Paulo, Brazil)|January 29, 2015
From one side to the other: what is essential? Perception of oncology patients and their caregivers in the beginning of oncology treatment and in palliative careBruna Antenussi Munhoz, Henrique Soares Paiva, Beatrice Martinez Zugaib Abdalla, et al.
The British Journal of Dermatology|February 20, 2026
Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanomaGeorg Lodde, Jonida Dollani, Wolfgang Galetzka, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2026
Exploring the gap between sensor-detected (SDH) and person-reported hypoglycaemia (PRH): The voice of people living with diabetesMonika Cigler, Omaima El-Hakouni, Renald Mecani, et al.
The British Journal of Dermatology|February 18, 2020
GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanomaE Livingstone, A Zaremba, S Horn, et al.
Diabetologia|July 30, 2024
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS appUffe Søholm, Melanie Broadley, Natalie Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyCarl M Thielmann, Johanna Matull, Anne Zaremba, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2023
Characterisation and outcome of RAC1 mutated melanomaGeorg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Pageof 97